XELJANZ (tofacitinib) Patient Assistance Program
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Xeljanz (tofacitinib) is FDA-approved for moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, moderate-to-severe ulcerative colitis, polyarticular course juvenile idiopathic arthritis (≥2 years), and ankylosing spondylitis. It is a JAK1/JAK3 inhibitor. Xeljanz XR is the once-daily extended-release formulation.m
- Without assistance, brand Xeljanz costs commonly run approximately $5,200–$6,200 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Xeljanz for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic tofacitinib is now available in the U.S. (2025) at substantially lower cost. Other JAK inhibitors include baricitinib (Olumiant), upadacitinib (Rinvoq), abrocitinib (Cibinqo), and ritlecitinib (Litfulo). TNF biosimilars (adalimumab, infliximab) are widely available at lower cost than Xeljanz for many of the same indications.
What Is Xeljanz Prescription Assistance Program?
The Xeljanz Prescription Assistance Program is a manufacturer-sponsored initiative that provides Xeljanz at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for RA, PsA, UC, JIA, and ankylosing spondylitis patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, rheumatology/gastroenterology coordination, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, brand Xeljanz costs roughly $5,200–$6,200/month. Generic tofacitinib is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$6,000 | Save ~$5,930/mo |
| CVS Pharmacy (brand) | ~$6,200 | Save ~$6,130/mo |
| Walmart (brand) | ~$5,400 | Save ~$5,330/mo |
| Costco (brand) | ~$5,300 | Save ~$5,230/mo |
Generic tofacitinib | ~$1,500 | Generic low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Xeljanz Prescription Program?
The Patient Assistance Program is free to apply for and provides Xeljanz at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic tofacitinib now available at lower cost, we’ll help your prescriber determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Tykerb:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,200–$6,200 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Xeljanz assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Xeljanz Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Xeljanz:
Xeljanz (tofacitinib) is an oral JAK1/JAK3 inhibitor used to treat several immune-mediated inflammatory conditions. By blocking JAK signaling, Xeljanz disrupts cytokine signals that drive autoimmune disease. Xeljanz XR provides once-daily dosing for the same indications.
How Xeljanz Works:
Tofacitinib works by selectively inhibiting JAK1 and JAK3, which are enzymes that normal cytokines use to activate STAT transcription factors and drive inflammatory gene expression. By disrupting this cellular signaling pathway, the medication reduces the production of inflammatory cytokines that drive diseases like RA, PsA, and UC. This targeted action results in reduced joint inflammation, improved skin disease, and decreased mucosal inflammation. As an oral small molecule, it offers a more convenient alternative to injectable biologics, though it carries broader effects on the overall immune system.
Form and use:
This medication is available as Xeljanz immediate-release, typically dosed at 5 mg or 10 mg twice daily, and as Xeljanz XR, dosed at 11 mg or 22 mg once daily depending on the specific condition and treatment phase. It can be taken with or without food according to patient preference. Because of how it impacts the immune system, tuberculosis (TB) and viral hepatitis screenings are strictly required for all patients before starting the therapy.
Generic availability:
Generic tofacitinib became available in the United States in 2025, providing a substantially lower-cost alternative to the brand-name drugs Xeljanz and Xeljanz XR. Other alternative JAK inhibitors on the market include baricitinib, upadacitinib, abrocitinib, and ritlecitinib. Additionally, widely available TNF biosimilars for drugs like Humira and Remicade offer lower-cost options and serve as first-line treatments for many of the same inflammatory indications.
Warnings:
Xeljanz carries multiple Boxed Warnings highlighting risks of serious infections like TB, higher all-cause and cardiovascular mortality, malignancies such as lymphoma, major adverse cardiovascular events, and thrombosis. Other notable safety warnings include risks of gastrointestinal perforation, embryo-fetal toxicity, hypersensitivity reactions, and laboratory abnormalities like lipid changes or anemia. Due to these significant class-effect risks, careful patient selection is necessary, and mandatory screenings for TB and viral hepatitis must be completed prior to initiation.
FAQ (Frequently Asked Questions)
How Much Does Xeljanz Cost Without Insurance?
Brand Xeljanz costs approximately $5,200–$6,200 per 30-day supply. Generic tofacitinib (now available) is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Xeljanz at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why The Multiple Boxed Warnings?
Brand Xeljanz costs approximately $5,200–$6,200 per 30-day supply. Generic tofacitinib (now available) is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Xeljanz at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Xeljanz Different From Rinvoq Or Olumiant?
All are JAK inhibitors with similar boxed warnings. Xeljanz blocks JAK1/JAK3. Olumiant blocks JAK1/JAK2. Rinvoq selectively blocks JAK1. Each has somewhat different FDA-approved indications and may have slightly different side-effect profiles. With generic tofacitinib now available, generic Xeljanz is often the cheapest JAK inhibitor option.
Should I Consider A TNF Biosimilar Instead?
Often yes — depending on your indication and clinical situation. TNF biosimilars (adalimumab biosimilars, infliximab biosimilars) are widely available at substantially lower cost than brand TNF blockers AND have a more reassuring long-term safety profile than JAK inhibitors. Current ACR guidelines and many insurance plans prefer TNF biosimilars over JAK inhibitors for many RA patients, especially older patients with cardiovascular risk factors. Discuss with your rheumatologist.
Do I Need TB Or Hepatitis Testing?
Yes. Latent TB testing (PPD or QuantiFERON-Gold) and hepatitis B/C screening are required before starting. JAK inhibitors can reactivate latent TB and hepatitis B.
Can I Get Xeljanz Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. With generic tofacitinib now available, Medicare patients may find the generic at low cost through standard Part D coverage.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic tofacitinib (substantially cheaper), to a TNF biosimilar (often preferred safety profile and lower cost), or to another biologic, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Arthritis Foundation, Crohn’s & Colitis Foundation, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee
Take Control of Your Medication Costs
If you are struggling with the high cost of Xeljanz, our team may be able to help you access assistance programs — or guide you to generic tofacitinib or a TNF biosimilar if it fits your situation. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.